GlassScriptPhysician profile
Cynthia Ko
NPI 1649529256
$6,452.18
in general payments reported to CMS, 2019-2025
15 companies · $2,206 in 2025
The $2,206 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $544 · 2021: $867 · 2022: $715 · 2023: $1,056 · 2024: $911 · 2025: $2,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,173.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,132.05 | 2019-2025 | Aristada, Lybalvi, Vivitrol |
| Janssen Pharmaceuticals, INC | $1,055.38 | 2019-2025 | Invega Sustenna |
| Neurocrine Biosciences, INC. | $918.14 | 2019-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $907.55 | 2020-2025 | Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $893.44 | 2019-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Lundbeck LLC | $560.62 | 2020-2025 | Abilify Asimtufii, Abilify Maintena |
| E.R. Squibb & Sons, L.L.C. | $285.92 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $186.79 | 2020-2025 | Caplyta |
| Bioxcel Therapeutics, INC. | $177.80 | 2023-2024 | Igalmi |
| Vanda Pharmaceuticals INC. | $114.70 | 2025 | Fanapt |
| Abbvie INC. | $78.15 | 2023-2025 | |
| Sunovion Pharmaceuticals INC. | $68.32 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $28.14 | 2025 | Invega Sustenna |
| Corium, LLC | $23.23 | 2023 | Azstarys |
| Uswm, LLC | $21.95 | 2024 | Lucemyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.